The National Institute of Diabetes and Digestive and Kidney Diseases, U.S. defines constipation as "condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass‟. Constipation is classified into two categories: functional constipation and secondary constipation. Functional constipation if further categorized into normal transit, slow transit and outlet constipation; secondary constipation is caused due to external medical conditions or intake of certain medications. Prime risk factors associated with constipation include age, low-caloric and low-fiber food intake, change in routine and taking excessive of medications such as antidepressants, pain killers, hypertension drugs and others.
Treatment for constipation may include change in dietary intake and nutrition, lifestyle changes, and medication. Bulk forming laxatives, osmotic laxatives, lubricants, stimulant laxatives and others are the laxative types preferred for medically treating constipation. Saline laxatives is a section of osmotic laxatives where the active ingredients are magnesium, sulfate, citrate, and phosphate ions.
For the purpose of this study, the global saline laxatives market is studied for drugs and prescription type. Magnesium Citrate, Magnesium Hydroxide and Sodium Phosphates are the major saline laxative drugs studied in this report. Further this market is also studied based on their prescribed and over-the-counter sales.
Along with market assessment in terms of historical, current and future market sizes, qualitative information sets such as market dynamics (drivers, challenges and opportunities), and executive summary for the global saline laxatives market are included in the report. Competition assessment for major market players and attractive investment proposition tool for the geographic markets are also included in the report for overall market competition scrutiny. This study concludes with company profiles section, which includes major information about the key companies engaged in development, manufacture and sale of saline laxatives.
Saline laxatives are milder forms of mainstream laxatives and are mostly used for rapid emptying of bowel. These drugs are often used for preparation before surgery, for elimination of foods and drugs after poisoning or to obtain fresh stool sample. Saline laxatives work by absorbing fluid into the bowel thus softening the stools, enabling their rapid discharge. Saline laxatives contain magnesium, citrate, sulphate and phosphate ions as active ingredients. Milk of Magnesia and Fleet phosphor-soda are the most renowned saline laxatives commercially available. The demand for OTC saline laxatives is the highest. However, their excessive and un-scrutinized use is discouraged on the grounds of reported renal failure, nephrocalcinosis and acute phosphate nepthropathy.
Geographically, the saline laxatives market is cumulative to North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
North America dominates the saline laxatives market both in terms of consumption and revenue generation followed by Europe. High use of medication for mild constipation, greater awareness and wide availability of a range of products are the key factors contributing to the dominance of these regions. Latin America is anticipated to follow the trends prevalent in North America market. Asia-Pacific is anticipated to be the fastest growing market among all the regions. Gradual growth in awareness in the patient population, growing availability of cost-effective drugs are the key factors driving the Asia-Pacific markets. Growing prevalence of constipation in this region and large pool of target geriatric population are among the other drivers contributing to the growth of Asia-Pacific saline laxatives market.
Saline laxatives form a very small section of the overall laxative drugs available in the market. High prevalence of constipation and corresponding lack of reporting until acute stages contribute to high levels of self-prescription of laxatives. Osmotic laxatives have been available for decades in the market, and patent protection of these products has long expired. These factors significantly contribute to the larger market share of over-the-counter sales of saline laxatives. However, the reported risk of acute phosphate nephropathy in patients has led to a controlled restrain on excessive OTC demand for saline laxatives. The demand for mild saline laxatives such as oral magnesium hydroxide is observed to be higher through OTC sales.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Saline Laxatives market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Drugs
| |
Prescription Type
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report